Finance

Lists
2395:TYO
Shin Nippon Biomedical Laboratories Ltd
1 443,00 JPY
+1,26%
(+18,00) 1D
9 ოქტ, 15:30:00 GMT+9  ·   JPY
All symbols
SymbolPriceChange% Change
Generating top insights for 2395...
Open
1 415 JPY
High
1 455 JPY
Low
1 415 JPY
Mkt. cap
60,08 მლრდ.
Avg. vol.
193,84 ათ.
Volume
162,90 ათ.
Dividend
3,47%
Quarterly dividend
13 JPY
Ex-dividend date
29 სექ. 2026
P/E ratio
11,19
52-wk high
2 005 JPY
52-wk low
1 067 JPY
EPS
129 JPY
Shares outstanding
41,63 მლნ.
No. of employees
2 ათ.
Open
1 415 JPY
High
1 455 JPY
Low
1 415 JPY
Mkt. cap
60,08 მლრდ.
Avg. vol.
193,84 ათ.
Volume
162,90 ათ.
Dividend
3,47%
Quarterly dividend
13 JPY
Ex-dividend date
29 სექ. 2026
P/E ratio
11,19
52-wk high
2 005 JPY
52-wk low
1 067 JPY
EPS
129 JPY
Shares outstanding
41,63 მლნ.
No. of employees
2 ათ.
News stories
From web sources and news partners
About Shin Nippon Biomedical Laboratories Ltd
CEO-
Employees1,68 ათ.
Founded1957
Headquarters-
SectorHealth care
Websitesnbl.co.jp
Previous reportsAll values in JPY
Loading Previous Earnings...
Revenue
Net income
All values in JPY
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
8,29 მლრდ.
6,43 მლრდ.
11,33 მლრდ.
7,87 მლრდ.
Cost of goods sold
4,68 მლრდ.
2,20 მლრდ.
6,00 მლრდ.
3,82 მლრდ.
Cost of revenue
4,68 მლრდ.
2,20 მლრდ.
6,00 მლრდ.
3,82 მლრდ.
Research and development expenses
-
-
2,40 მლრდ.
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3,22 მლრდ.
3,25 მლრდ.
850,24 მლნ.
3,53 მლრდ.
Operating expense
3,22 მლრდ.
3,25 მლრდ.
3,70 მლრდ.
3,53 მლრდ.
Total operating expenses
7,90 მლრდ.
5,45 მლრდ.
9,70 მლრდ.
7,35 მლრდ.
Operating income
389,94 მლნ.
978,59 მლნ.
1,63 მლრდ.
521,74 მლნ.
Other non operating income
54,56 მლნ.
81,03 მლნ.
107,77 მლნ.
2,88 მლნ.
EBT including unusual items
990,50 მლნ.
1,43 მლრდ.
3,50 მლრდ.
1,41 მლრდ.
EBT excluding unusual items
1,11 მლრდ.
1,49 მლრდ.
2,71 მლრდ.
1,43 მლრდ.
Income tax expense
209,00 მლნ.
229,77 მლნ.
1,20 მლრდ.
345,37 მლნ.
Effective tax rate
21,10%
16,11%
34,24%
24,52%
Other operating expenses
-
-
-
-
Net income
800,58 მლნ.
1,21 მლრდ.
2,30 მლრდ.
1,06 მლრდ.
Net profit margin
9,66%
18,82%
20,26%
13,52%
Earnings per share
-
-
-
-
Interest and investment income
88,32 მლნ.
14,12 მლნ.
128,12 მლნ.
12,42 მლნ.
Interest expense
-68,18 მლნ.
-78,15 მლნ.
-88,40 მლნ.
-106,94 მლნ.
Net interest expenses
20,13 მლნ.
-64,03 მლნ.
39,72 მლნ.
-94,52 მლნ.
Depreciation and amortization charges
-
-
411,00 მლნ.
-
EBITDA
1,17 მლრდ.
1,63 მლრდ.
2,48 მლრდ.
1,38 მლრდ.
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google აპები